The burden of adverse drug events

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 2015 English Publisher:WileyJournal:British Journal of Clinical Pharmacology, volume 80, pages 785-787 (issn: 0306-5251, eissn: 1365-2125,

Copyright policy )

Authors: Alasdair, Breckenridge;

doi: 10.1111/bcp.12507

pmid: 25205165

pmc: PMC4594720

The burden of adverse drug events

- Summary
- Subjects
- Metrics

Abstract

Drug safety should be considered as part of the balance between benefit and risk, and represents a burden to the patient, the healthcare professional, the regulator and industry. Each of these has a different view on adverse drug reactions and these are discussed in this article.

Related Organizations

University of Liverpool
United Kingdom

Keywords

Drug Industry, Drug-Related Side Effects and Adverse Reactions, Patients, Health Personnel, Government Regulation, Humans, Risk Assessment

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	8
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average